About
Aptevo Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 3 2026
Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth
Jan 9 2026
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality
Dec 26 2025
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
Dec 26 2025
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split
Dec 9 2025
Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025
Recent Videos

APVO Stock (Aptevo Therapeutics stock analysis) APVO STOCK PREDICTION APVO STOCK analysis
Apr 28, 2026

2025-06-18 08:01:28 APVO Level 2 and Time & Sales
Apr 26, 2026

APVO Stock (Aptevo Therapeutics stock analysis) APVO STOCK PREDICTION APVO STOCK analysis
Apr 23, 2026

APVO Stock (Aptevo Therapeutics stock analysis) APVO STOCK PREDICTION APVO STOCK analysis
Apr 21, 2026
Google Übersetzer